Precision Biosciences (DTIL)Officer sold ~$4.8K
Dario Scimeca, Officer at Precision Biosciences, sold ~$4.8K of Precision Biosciences shares.
- ~$4.8K
- Approx. value · 588 sh @ $8.19
- 7,969
- Holds after · shares reported
- Traded
- Nov 4, 2024
- Filed
- Nov 6, 2024
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Nov 4, 2024 · this disclosureInsiderOfficer sold ~$4.8K of DTIL shares in the open market
What came next
- Nov 4, 2024InsiderCEO sold ~$25K of DTIL shares in the open market
- Nov 21, 2024InsiderCFO purchased ~$20K of DTIL shares in the open market
- Dec 26, 2024InsiderDirector purchased ~$14K of DTIL shares in the open market
- Dec 27, 2024Insider · 2 peopleInsiders: 2 purchases (~$31K)
- Dec 30, 2024InsiderDirector purchased ~$16K of DTIL shares in the open market
- Jan 21, 2025InsiderCEO sold ~$172K of DTIL shares in the open market
- Jan 22, 2025Insider · 2 peopleInsiders: 2 sales (~$92K)
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Precision Biosciences
For Precision Biosciences, OQRO holds 3 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DTIL page.
Other recent filings by Dario Scimeca, General Counsel and Secretary
- SEC Form 4 at Precision Biosciences (DTIL)Feb 19, 2026
- SEC Form 4 at Precision Biosciences (DTIL)Jan 22, 2026
- SEC Form 4 at Precision Biosciences (DTIL)Nov 4, 2025
- SEC Form 4 at Precision Biosciences (DTIL)Mar 6, 2025
- SEC Form 4 at Precision Biosciences (DTIL)Jan 23, 2025
The full history of Dario Scimeca, General Counsel and Secretary is on the profile page.
How this filing works
Other disclosures at Precision Biosciences
- SEC Form 4Sep 30, 2026
- SEC Form 4Sep 29, 2026
- SEC Form 4Sep 29, 2026
- SEC Form 4Feb 19, 2026
- SEC Form 4Feb 19, 2026
- SEC Form 4Feb 19, 2026
Everything OQRO holds on this company is on its DTIL page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
